Explore the full directors' dealings record of 海尔生物, a listed issuer based in France. Shares are listed on FR FR, under the oversight of AMF. Market capitalisation: €10.1bn. The latest transaction was filed on 31 October 2024 (Purchase). Among the most active insiders: 江兰. Every trade is openly available.